Background and Purpose-Familial hypercholesterolemia (FH) is a common autosomal dominant disease leading to increased level of serum LDL (low-density lipoprotein) cholesterol and risk of coronary heart disease. Whether FH increases the risk of cerebrovascular disease, including ischemic stroke, is debated. Accordingly, we studied the incidence of cerebrovascular disease in a cohort of people with genetically verified FH compared with the entire Norwegian population and examined whether people in this cohort with previous cohort had increased risk of cerebrovascular disease. Methods-Incidence rates of hospitalization for cerebrovascular disease (among 3144 people with FH) and ischemic stroke (among 3166 people with FH) were estimated by linkage of FH people to Cardiovascular Disease in Norway-a nationwide database of cardiovascular disease hospitalizations (2001-2009). We calculated standardized incidence ratios and used Cox regression to estimate hazard ratios. Results-A total of 46 cases (19 women and 27 men) of cerebrovascular disease were observed in the cohort of people with FH, with no increased risk of cerebrovascular disease compared with the general population (standardized incidence ratio, 1.0; 95% CI, 0.8-1.4). Total number of ischemic strokes in the cohort of people with FH was 26 (9 women and 17 men), with no increased risk compared with the general population (standardized incidence ratio, 1.0; 95% CI, 0.7-1.5).
S
troke is an important cause of disability and death worldwide, 1 and there are several risk factors for stroke, such as hypertension, carotid artery atherosclerosis, and smoking. 2 Atherosclerosis is an underlying factor for stroke, and accordingly, LDL (low-density lipoprotein) cholesterol-lowering therapy is important in both primary and secondary prevention of cerebrovascular diseases, including stroke. 3 People with heterozygous familial hypercholesterolemia (FH) have increased levels of LDL cholesterol from birth 4 and increased risk of premature coronary heart disease (CHD) and heart failure because of the increased LDL cholesterol load. [5] [6] [7] With the increased risk of atherosclerosis, the risk of stroke in patients with FH is expected to be high. However, whether the risk of stroke in patients with FH is increased has been debated, and previous studies have yielded inconsistent results. 8, 9 Our aim was to investigate risk of cerebrovascular disease, including ischemic stroke, in a genetically verified cohort of people with FH in comparison with the risk in the entire Norwegian population. In addition, we aimed to examine whether previous hospitalization for CHD was associated with the risk of cerebrovascular disease, including ischemic strokes.
Cardiovascular Genetics Registry linked to the Norwegian Cause of Death Registry and the Cardiovascular Disease in Norway project database. Data used in this project cannot be made available for researchers without new approvals because of data protection legislation in Norway.
All patients with genetically diagnosed FH in Norway are included in the National Unit for Cardiac and Cardiovascular Genetics Registry after written informed consent. Before the registry linkage, all patients received a letter and were offered to be removed from the list and not participate in the registry linkage.
An incident event of cerebrovascular disease was defined as a hospitalization with cerebrovascular disease as main or secondary diagnosis or death with cerebrovascular disease as the underlying cause, without any prior hospitalizations with cerebrovascular disease during the past 7 years. Patients were followed from inclusion in the FH registry until the first occurrence of cerebrovascular disease, death, or December 31, 2009, whichever came first. Incident events of ischemic stroke were defined in the same manner. We calculated incidence rates and standardized incidence ratios (with 95% CIs) for cerebrovascular disease and ischemic stroke using incidence rates for the total Norwegian population as reference rates. The association between CHD and risk of cerebrovascular disease was analyzed by including CHD as a time-dependent covariate in a Cox regression, reported as hazard ratios with 95% CIs. Further details are provided in Methods in the online-only Data Supplement.
Results
In A total of 46 cases of cerebrovascular disease were observed in people with FH, 19 women and 27 men, and no significant increased risk of cerebrovascular disease was found (Table) . When ischemic strokes were analyzed, 26 ischemic strokes were observed (9 women and 17 men) and again, no significant increased risk in people with FH (Table) .
In the group of 46 patients with cerebrovascular disease, 23 (50%) had previous CHD, 11 women (57.9%) and 12 men (44.4%). In Cox regression analyses of the association between CHD and cerebrovascular disease, we found a significant interaction between sex and CHD (P interaction =0.04). In separate analyses for men and women, a significant association between previous CHD and risk of cerebrovascular disease was found in women (hazard ratio, 3.29; 95% CI, 1.20-9.00) but not in men (hazard ratio, 1.03; 95% CI, 0.45-2.37).
Discussion
In our cohort of 3170 genetically verified people with FH and >18 500 person-years of follow-up, there was no increased incidence of cerebrovascular disease or ischemic stroke compared with the entire population of Norway, and as far as we know, this is the largest data set to date investigating this. Acknowledging the contribution of age to the risk of cerebrovascular disease, mean age at inclusion was relatively low in our cohort.
The finding of no increased risk of cerebrovascular disease and ischemic stroke in people with high LDL cholesterol from birth is interesting and challenges the concept of LDL cholesterol being a major risk factor for cerebrovascular disease and ischemic stroke. Importantly, in the present cohort, the risk of CHD was >4-fold increased during the same period of time. 6 A Mendelian randomization study recently found that people with lifelong low levels of PCSK9 (proprotein convertase subtilisin/kexin type 9) and LDL cholesterol had lower risk of CHD but with no effect on ischemic stroke. 10 This has questioned the relation between LDL cholesterol and ischemic strokes. Indeed, much of the support for the LDL cholesterol hypothesis about the risk of ischemic stroke is based on the reduced incidence of stroke found in landmark statin trials. 11 However, the largest published meta-analysis of statin trials found only a small reduction in stroke risk among statintreated men and no effect on stroke incidence in women. 11 The results of most previous studies on cerebrovascular disease and stroke in people with FH are in agreement of our findings. 9, 12, 13 In contrast, Toell et al 8 recently demonstrated increased prevalence of ischemic strokes and transient ischemic attacks in people with FH, however, with FH defined by clinical criteria and not genetic criteria.
Previous hospitalization for CHD increased the risk of cerebrovascular disease in women in the present study but surprisingly not in men; this finding warrants further investigation because the sample is small. 
Conclusions
In this large cohort of 3170 genetically verified people with FH, with >18 500 person-years of follow-up, risks of cerebrovascular disease and ischemic stroke were not increased compared with the age, sex, and calendar year-adjusted Norwegian population, despite the previously reported higher risk of CHD in this cohort. Our results raise new questions on the specific role of LDL cholesterol in cerebrovascular disease and ischemic stroke.
